HEADER ANTIBIOTIC 18-MAY-20 7C4V TITLE MICROED STRUCTURE OF ANORTHIC VANCOMYCIN AT 1.05 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: VANCOMYCIN; COMPND 3 CHAIN: A, B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AMYCOLATOPSIS ORIENTALIS; SOURCE 3 ORGANISM_TAXID: 31958 KEYWDS MICROED, VANCOMYCIN, SUPERBACTERIA, ANTIBIOTIC EXPDTA ELECTRON CRYSTALLOGRAPHY AUTHOR Q.FAN,H.ZHOU,X.LI,J.WANG REVDAT 5 29-NOV-23 7C4V 1 REMARK LINK REVDAT 4 17-MAR-21 7C4V 1 JRNL REVDAT 3 26-AUG-20 7C4V 1 REMARK REVDAT 2 19-AUG-20 7C4V 1 REMARK REVDAT 1 12-AUG-20 7C4V 0 JRNL AUTH Q.FAN,L.LI,H.XUE,H.ZHOU,L.ZHAO,J.LIU,J.MAO,S.WU,S.ZHANG, JRNL AUTH 2 C.WU,X.LI,X.ZHOU,J.WANG JRNL TITL PRECISE CONTROL OVER KINETICS OF MOLECULAR ASSEMBLY: JRNL TITL 2 PRODUCTION OF PARTICLES WITH TUNABLE SIZES AND CRYSTALLINE JRNL TITL 3 FORMS. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 59 15141 2020 JRNL REFN ESSN 1521-3773 JRNL PMID 32432368 JRNL DOI 10.1002/ANIE.202003922 REMARK 2 REMARK 2 RESOLUTION. 1.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15_3459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.020 REMARK 3 COMPLETENESS FOR RANGE (%) : 66.0 REMARK 3 NUMBER OF REFLECTIONS : 6445 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.234 REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 323 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 7.8750 - 1.3220 0.65 3011 159 0.2265 0.2634 REMARK 3 2 1.3220 - 1.0501 0.67 3111 164 0.2445 0.2799 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.130 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 8.87 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7C4V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-MAY-20. REMARK 100 THE DEPOSITION ID IS D_1300017031. REMARK 240 REMARK 240 EXPERIMENTAL DETAILS REMARK 240 RECONSTRUCTION METHOD : CRYSTALLOGRAPHY REMARK 240 SAMPLE TYPE : 3D ARRAY REMARK 240 SPECIMEN TYPE : NULL REMARK 240 DATA ACQUISITION REMARK 240 DATE OF DATA COLLECTION : 01-JUN-19 REMARK 240 TEMPERATURE (KELVIN) : NULL REMARK 240 PH : NULL REMARK 240 NUMBER OF CRYSTALS USED : NULL REMARK 240 MICROSCOPE MODEL : FEI TECNAI F20 REMARK 240 DETECTOR TYPE : GATAN ULTRASCAN 4000 (4K X 4K) REMARK 240 ACCELERATION VOLTAGE (KV) : 200 REMARK 240 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 240 RESOLUTION RANGE HIGH (A) : NULL REMARK 240 RESOLUTION RANGE LOW (A) : NULL REMARK 240 DATA SCALING SOFTWARE : NULL REMARK 240 COMPLETENESS FOR RANGE (%) : NULL REMARK 240 DATA REDUNDANCY : NULL REMARK 240 IN THE HIGHEST RESOLUTION SHELL REMARK 240 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) :1.05 REMARK 240 HIGHEST RESOLUTION SHELL, RANGE LOW (A) :1.10 REMARK 240 COMPLETENESS FOR SHELL (%) : 66.9 REMARK 240 DATA REDUNDANCY IN SHELL : 6.83 REMARK 240 R MERGE FOR SHELL (I) : 0.41900 REMARK 240 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 240 SOFTWARE USED : NULL REMARK 240 STARTING MODEL : 1FVM REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 1440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 1450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS REMARK 400 A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L. IT IS REMARK 400 FURTHER GLYCOSYLATED BY A DISACCHARIDE MADE OF D-GLUCOSE REMARK 400 AND VANCOSAMINE. REMARK 400 HERE, VANCOMYCIN IS REPRESENTED BY GROUPING TOUGHER THE REMARK 400 SEQUENCE (SEQRES) AND THE TWO LIGANDS (HET) BGC AND RER. REMARK 400 REMARK 400 THE VANCOMYCIN IS GLYCOPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: VANCOMYCIN REMARK 400 CHAIN: A, B, C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 COMPONENT_2: RESIDUE BGC REMARK 400 COMPONENT_3: RESIDUE RER REMARK 400 DESCRIPTION: VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED REMARK 400 BY A DISACCHARIDE (RESIDUES 8 AND 9) ON RESIDUE 4. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O2 BGC D 1 C2 RER D 2 2.08 REMARK 500 O4 GHP A 4 O5 BGC C 1 2.09 REMARK 500 O HOH B 109 O HOH B 118 2.09 REMARK 500 O4 GHP B 4 O5 BGC D 1 2.14 REMARK 500 CZ OMZ A 2 C5 GHP A 4 2.19 REMARK 500 C3 GHP B 4 CZ OMY B 6 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 201 O HOH B 113 1655 2.15 REMARK 500 O HOH B 107 O HOH B 112 1455 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 3 -156.74 171.08 REMARK 500 ASN B 3 -151.93 177.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-30289 RELATED DB: EMDB REMARK 900 MICROED STRUCTURE OF ANORTHIC VANCOMYCIN AT 1.05 A RESOLUTION DBREF 7C4V A 1 7 PDB 7C4V 7C4V 1 7 DBREF 7C4V B 1 7 PDB 7C4V 7C4V 1 7 SEQRES 1 A 7 MLU OMZ ASN GHP GHP OMY 3FG SEQRES 1 B 7 MLU OMZ ASN GHP GHP OMY 3FG HET MLU A 1 9 HET OMZ A 2 14 HET GHP A 4 11 HET GHP A 5 11 HET OMY A 6 14 HET 3FG A 7 13 HET MLU B 1 9 HET OMZ B 2 14 HET GHP B 4 11 HET GHP B 5 11 HET OMY B 6 14 HET 3FG B 7 13 HET BGC C 1 11 HET RER C 2 10 HET BGC D 1 11 HET RER D 2 10 HET CL A 101 1 HETNAM MLU N-METHYL-D-LEUCINE HETNAM OMZ (BETAR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE HETNAM GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID HETNAM OMY (BETAR)-3-CHLORO-BETA-HYDROXY-L-TYROSINE HETNAM 3FG (2S)-AMINO(3,5-DIHYDROXYPHENYL)ETHANOIC ACID HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM RER VANCOSAMINE HETNAM CL CHLORIDE ION HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN RER (1R,3S,4S,5S)-3-AMINO-2,3,6-TRIDEOXY-3-METHYL-ALPHA-L- HETSYN 2 RER ARABINO-HEXOPYRANOSE FORMUL 1 MLU 2(C7 H15 N O2) FORMUL 1 OMZ 2(C9 H10 CL N O4) FORMUL 1 GHP 4(C8 H9 N O3) FORMUL 1 OMY 2(C9 H10 CL N O4) FORMUL 1 3FG 2(C8 H9 N O4) FORMUL 3 BGC 2(C6 H12 O6) FORMUL 3 RER 2(C7 H15 N O3) FORMUL 5 CL CL 1- FORMUL 6 HOH *43(H2 O) LINK C MLU A 1 N OMZ A 2 1555 1555 1.31 LINK C OMZ A 2 N ASN A 3 1555 1555 1.29 LINK OH OMZ A 2 C5 GHP A 4 1555 1555 1.37 LINK C ASN A 3 N GHP A 4 1555 1555 1.32 LINK C GHP A 4 N GHP A 5 1555 1555 1.31 LINK C3 GHP A 4 OCZ OMY A 6 1555 1555 1.37 LINK O4 GHP A 4 C1 BGC C 1 1555 1555 1.37 LINK C GHP A 5 N OMY A 6 1555 1555 1.33 LINK C3 GHP A 5 CG1 3FG A 7 1555 1555 1.48 LINK C OMY A 6 N 3FG A 7 1555 1555 1.32 LINK C MLU B 1 N OMZ B 2 1555 1555 1.31 LINK C OMZ B 2 N ASN B 3 1555 1555 1.29 LINK OH OMZ B 2 C5 GHP B 4 1555 1555 1.37 LINK C ASN B 3 N GHP B 4 1555 1555 1.31 LINK C GHP B 4 N GHP B 5 1555 1555 1.31 LINK C3 GHP B 4 OCZ OMY B 6 1555 1555 1.38 LINK O4 GHP B 4 C1 BGC D 1 1555 1555 1.37 LINK C GHP B 5 N OMY B 6 1555 1555 1.32 LINK C3 GHP B 5 CG1 3FG B 7 1555 1555 1.48 LINK C OMY B 6 N 3FG B 7 1555 1555 1.31 LINK O2 BGC C 1 C1 RER C 2 1555 1555 1.37 LINK O2 BGC D 1 C1 RER D 2 1555 1555 1.37 CISPEP 1 GHP A 5 OMY A 6 0 2.15 CISPEP 2 GHP B 5 OMY B 6 0 3.71 CRYST1 13.970 18.550 23.860 109.52 97.33 106.58 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.071582 0.021312 0.019014 0.00000 SCALE2 0.000000 0.056247 0.023803 0.00000 SCALE3 0.000000 0.000000 0.045884 0.00000 HETATM 1 N MLU A 1 5.988 -11.464 3.055 1.00 7.78 N ANISOU 1 N MLU A 1 464 1470 1021 -64 -48 544 N HETATM 2 CN MLU A 1 6.336 -12.488 2.086 1.00 8.23 C ANISOU 2 CN MLU A 1 570 1500 1057 -44 22 550 C HETATM 3 CA MLU A 1 5.107 -10.474 2.475 1.00 7.42 C ANISOU 3 CA MLU A 1 454 1394 973 -81 -73 545 C HETATM 4 C MLU A 1 3.847 -11.068 2.015 1.00 6.60 C ANISOU 4 C MLU A 1 421 1234 853 -104 -98 503 C HETATM 5 O MLU A 1 3.260 -11.933 2.750 1.00 6.69 O ANISOU 5 O MLU A 1 414 1284 842 -56 -42 529 O HETATM 6 CB MLU A 1 4.767 -9.521 3.587 1.00 8.74 C ANISOU 6 CB MLU A 1 730 1506 1086 30 91 634 C HETATM 7 CG MLU A 1 3.692 -8.549 3.157 1.00 9.75 C ANISOU 7 CG MLU A 1 986 1567 1152 110 271 710 C HETATM 8 CD1 MLU A 1 3.324 -7.728 4.387 1.00 10.41 C ANISOU 8 CD1 MLU A 1 1135 1613 1208 213 380 739 C HETATM 9 CD2 MLU A 1 4.310 -7.645 2.100 1.00 10.02 C ANISOU 9 CD2 MLU A 1 1059 1565 1182 106 321 723 C HETATM 10 N OMZ A 2 3.417 -10.690 0.837 1.00 6.50 N ANISOU 10 N OMZ A 2 414 1236 820 -61 -81 499 N HETATM 11 CA OMZ A 2 2.231 -11.128 0.398 1.00 6.20 C ANISOU 11 CA OMZ A 2 412 1162 781 -77 -109 470 C HETATM 12 C OMZ A 2 1.524 -10.107 -0.411 1.00 5.82 C ANISOU 12 C OMZ A 2 408 1063 741 -82 -126 446 C HETATM 13 O OMZ A 2 2.248 -9.231 -0.952 1.00 5.88 O ANISOU 13 O OMZ A 2 410 1072 753 -62 -101 478 O HETATM 14 CB OMZ A 2 2.439 -12.380 -0.454 1.00 6.51 C ANISOU 14 CB OMZ A 2 415 1232 829 -78 -102 468 C HETATM 15 OC OMZ A 2 3.366 -12.207 -1.384 1.00 6.57 O ANISOU 15 OC OMZ A 2 414 1252 831 -145 -80 446 O HETATM 16 CG OMZ A 2 1.204 -12.781 -1.062 1.00 7.02 C ANISOU 16 CG OMZ A 2 458 1305 905 -9 -107 495 C HETATM 17 CD1 OMZ A 2 0.269 -13.487 -0.352 1.00 7.56 C ANISOU 17 CD1 OMZ A 2 529 1357 985 15 -57 494 C HETATM 18 CD2 OMZ A 2 1.028 -12.557 -2.419 1.00 7.14 C ANISOU 18 CD2 OMZ A 2 491 1304 916 14 -146 466 C HETATM 19 CE1 OMZ A 2 -0.862 -13.889 -0.991 1.00 8.17 C ANISOU 19 CE1 OMZ A 2 662 1396 1046 64 -34 449 C HETATM 20 CL OMZ A 2 -2.052 -14.702 -0.149 1.00 9.71 CL ANISOU 20 CL OMZ A 2 989 1542 1157 215 130 459 CL HETATM 21 CE2 OMZ A 2 -0.107 -12.967 -3.039 1.00 7.39 C ANISOU 21 CE2 OMZ A 2 528 1329 949 40 -142 441 C HETATM 22 CZ OMZ A 2 -1.047 -13.646 -2.332 1.00 7.44 C ANISOU 22 CZ OMZ A 2 533 1304 991 30 -136 396 C HETATM 23 OH OMZ A 2 -2.126 -14.053 -2.943 1.00 6.99 O ANISOU 23 OH OMZ A 2 477 1196 984 31 -131 325 O